New Warnings Could Be Added By Generic Drug Makers Under Proposed FDA Rule

New Warnings Could Be Added By Generic Drug Makers Under Proposed FDA Rule

SILVER SPRING, Md. - The Food and Drug Administration on Nov. 8 proposed a new rule that would allow generic drug manufacturers to add new warnings to their drug labels without waiting for action by the makers of brand-name predecessor drugs.

Find full version on lexis Advance®
Access this news story on lexis.com®